Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06190808 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring in the Intensive Care Unit
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT06190808 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 16 participants.
The verdict
NCT06190808, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The aim of the proposed clinical trial is to study the use of the Dexcom G7 continuous glucose monitor (CGM) within the intensive care unit (ICU) environment. The overall goal is to validate the accuracy and practicality of the Dexcom G7 when used to assess glycemia in critically ill patients.
Interventions
- DIAGNOSTIC_TEST Dexcom G7 Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-02-20 |
| Est. Completion | 2025-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06190808
The ClinicalTrials.gov registry entry for NCT06190808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G7 Continuous Glucose Monitor is the first listed.
NCT06190808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06190808 about?
NCT06190808 is a clinical study titled "Continuous Glucose Monitoring in the Intensive Care Unit". The aim of the proposed clinical trial is to study the use of the Dexcom G7 continuous glucose monitor (CGM) within the intensive care unit (ICU) environment. The overall goal is to validate the accuracy and practicality of the Dexcom G7 when used to assess glycemia in critically ill patients.
What is the current status of trial NCT06190808?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2024-02-20. Estimated completion is 2025-07-25.
What interventions are being tested in trial NCT06190808?
The interventions under investigation include: Dexcom G7 Continuous Glucose Monitor (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06190808?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.